We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI to Provide Heart Transplant Surgeons with New Decision-Making Data

By HospiMedica International staff writers
Posted on 11 Apr 2024
Print article
Image: Artificial intelligence can significantly impact the heart transplantation process (Photo courtesy of 123RF)
Image: Artificial intelligence can significantly impact the heart transplantation process (Photo courtesy of 123RF)

Until now, surgeons have evaluated the likelihood of a successful heart transplant based on individual risk factors. Now, new research presented at ISHLT 2024 has revealed that artificial intelligence (AI) can help physicians better assess the complex factors impacting patient outcomes and have a significant impact on the heart transplantation process.

Surgeons at the Cleveland Clinic (Cleveland, OH, USA) are developing a decision-support tool for transplant surgeons using a modeling technique known as ‘digital twinning.’ This innovative approach involves creating a digital picture of each transplant recipient to assist physicians in predicting patient outcomes using specific data combinations. The surgical team has established a comprehensive database that incorporates clinical data and test results from all 600 heart recipients and donors since the start of their transplant program.

To further enhance this database, the team is currently sequencing the whole genomes of both the recipients and their donors. Plans are in place to continually update the database with new data gathered from ongoing monitoring of heart recipients, including metrics like heart rate, blood oxygen levels, and biopsy results. The integration of AI with this rich data pool is expected to refine organ allocation systems significantly, enabling more accurate predictions of patient outcomes throughout the transplantation process.

“I think our guidelines will change because we’ll be able to look at combinations of weighted risk factors and how they interplay,” said Eileen Hsich, medical director of the Heart Transplant Program at the Cleveland Clinic. “That work cannot be done manually. Machine learning can provide data we’ve never had before, and it will make a big difference.”

Related Links:
Cleveland Clinic

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Neonatal and Pediatric Tracheostomy Tubes
Portex Bivona FlexTend TTS Tracheostomy Tubes
New
LED Phototherapy System
neoBLUE compact

Print article

Channels

Critical Care

view channel
Image: Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived (Photo courtesy of American Heart Association)

Injecting Clot-Dissolving Drug After Removing Large Brain Artery Clot Improves Stroke Outcomes

Approximately 1 in 5 ischemic strokes, which are caused by a clot, occur due to a blockage in a large artery in the brain (large vessel occlusions). The standard treatment for this type of stroke is the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.